NRG1 and atherosclerosis: Stimulation of ErbB3 by NRG1β has been reported to inhibit EC proliferation (Amin et al., 2006), and ErbB3 may be a potential therapeutic target of the NRG1-ErbB pathway against atherosclerosis.